Rapport Therapeutics, Inc.

NasdaqGM:RAPP Stock Report

Market Cap: US$697.1m

Rapport Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:RAPP Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
01 Jul 24BuyUS$1,079,575Synergy Capital LimitedCompany44,032US$26.06
10 Jun 24BuyUS$8,316,910Sofinnova Investment, Inc.Company489,230US$17.00
10 Jun 24BuyUS$1,183,098Synergy Capital LimitedCompany69,594US$17.00

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of RAPP?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders2,479,4206.78%
Hedge Funds2,940,2838.04%
General Public8,017,93821.9%
Institutions9,423,65925.8%
VC/PE Firms13,715,15737.5%

Dilution of Shares: RAPP only recently listed within the past 12 months

Top Shareholders

Top 22 shareholders own 78.08% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
22.2%
Third Rock Ventures, LLC
8,104,451US$154.5m0%40.34%
13.6%
FMR LLC
4,983,351US$95.0m0%0.01%
10.2%
Arch Venture Partners, L.P.
3,728,738US$71.1m0%6.33%
8.04%
Cormorant Asset Management, LP
2,940,283US$56.0m0%2.96%
5.15%
Sofinnova Investment, Inc.
1,881,968US$35.9m0%2.25%
4.76%
Capital Research and Management Company
1,740,922US$33.2m0%no data
2.68%
Goldman Sachs Asset Management, L.P.
980,730US$18.7m0%0.01%
2.16%
Abraham Ceesay
789,703US$15.1m0%no data
1.6%
Johnson & Johnson Innovation - JJDC, Inc.
583,784US$11.1m0%3.01%
1.31%
David Bredt
477,642US$9.1m0%no data
1.31%
Steven Paul
477,642US$9.1m0%no data
1.11%
T. Rowe Price Group, Inc.
407,374US$7.8m0%no data
0.8%
Swamy Yeleswaram
290,831US$5.5m0%no data
0.64%
Broad Street Principal Investments, L.L.C.
233,735US$4.5m0%19.22%
0.54%
Bradley Galer
197,426US$3.8m0%no data
0.43%
Cheryl Gault
157,941US$3.0m0%no data
0.38%
AllianceBernstein L.P.
138,392US$2.6m0%no data
0.31%
Synergy Capital Limited
113,626US$2.2m0%no data
0.28%
TD Asset Management, Inc.
101,522US$1.9m0%no data
0.24%
James Healy
88,235US$1.7m0%no data
0.19%
Goldman Sachs Group, Investment Banking and Securities Investments
70,723US$1.3m0%no data
0.19%
The Vanguard Group, Inc.
69,500US$1.3m0%no data
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.